Social Media

By Kathy Barry and Colby Rogers, as published in PM360, November 22, 2022 […] Many of biopharma’s most exciting innovations come from the field of rare and ultra-rare diseases. With the development of new technology platforms at breakneck speed, companies are positioning themselves to one day deliver game-changing solutions to patients in their niche—solutions they […]
Updated on October 25, 2022 At the PM360 Trailblazer Awards last night, SNOW’s initiatives went from Finalist status to Gold and Silver winners. The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries. Each of the winners were judged and selected by the PM360 Editorial Advisory […]
The RUCONEST® (C1 esterase inhibitor [recombinant]) Account Takeovers have been selected as this year’s Innovative Strategy in the PM360 Innovations Issue. In 2021, Pharming partnered with Snow Companies to transform RUCONEST’s social media channels. We launched four patient “account takeovers” of Pharming’s Facebook and Instagram accounts. During the campaign, four hereditary angioedema (HAE) patients each published separate weekday posts […]